When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis
Saved in:
Main Authors: | Prince FHM (Author), Twilt M (Author), Simon SCM (Author), van Rossum MAJ (Author), Armbrust W (Author), Hoppenreijs EPAH (Author), Kamphuis SSM (Author), van Santen-Hoeufft M (Author), Koopman-Keemink Y (Author), Wulffraat N (Author), ten Cate R (Author), van Suijlekom-Smit LWA (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2008-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a web-based register for the Dutch national study on biologicals in juvenile idiopathic arthritis: <url>http://www.abc-register.nl</url>
by: Prince FHM, et al.
Published: (2008) -
Etanercept in juvenile idiopathic arthritis: Who will benefit?
by: van den Berg JM, et al.
Published: (2011) -
Parental preferences for treatment: Preliminary report from a randomised comparison of treatment strategies in (early) juvenile idiopathic arthritis (BeSt for Kids trial)
by: van Rossum MAJ, et al.
Published: (2011) -
Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial
by: Bastiaan T. van Dijk, et al.
Published: (2024) -
Association of the <it>CCR5</it>Δ32 variant with juvenile idiopathic arthritis in a meta-analysis
by: Toes REM, et al.
Published: (2011)